PF4 and Thrombocytopenia: The immunological thrombotic thrombocytopenia potentially associated with the ChAdOx1 nCoV-19 vaccine is clinically similar to severe heparin-induced thrombocytopenia when platelet-activating antibodies against platelet factor 4 (PF4) are present [79,80].